Hepatic Peroxisome Proliferator-Activated Receptor γ Coactivator 1α and Hepcidin Are Coregulated in Fasted/Refed States in Mice

被引：2
|
作者：
Deschemin, Jean-Christophe [1 ,2 ,3 ]
Foretz, Marc [1 ,2 ,3 ]
Viollet, Benoit [1 ,2 ,3 ]
Vaulont, Sophie [1 ,2 ,3 ]
机构：
[1] Fac Med Cochin, Inst Cochin, INSERM, U1016, F-75014 Paris, France
[2] CNRS, UMR8104, Paris, France
[3] Univ Paris 05, Paris, France
来源：
CLINICAL CHEMISTRY | 2012年 / 58卷 / 10期
关键词：
METABOLISM;
D O I：
10.1373/clinchem.2012.192195
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：1487 / 1488
页数：2
相关论文
共 50 条
  • [1] Hepatic-specific activation of peroxisome proliferator-activated receptor γ coactivator-1β protects against steatohepatitis
    Bellafante, Elena
    Murzilli, Stefania
    Salvatore, Lorena
    Latorre, Dominga
    Villani, Gaetano
    Moschetta, Antonio
    HEPATOLOGY, 2013, 57 (04) : 1343 - 1356
  • [2] The Role of Peroxisome Proliferator-Activated Receptor γ Coactivator 1α (PGC-1α) in Kidney Disease
    Li, Szu-Yuan
    Susztak, Katalin
    SEMINARS IN NEPHROLOGY, 2018, 38 (02) : 121 - 126
  • [3] Peroxisome proliferator-activated receptor-γ coactivator-1α in muscle links metabolism to inflammation
    Handschin, Christoph
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2009, 36 (12) : 1139 - 1143
  • [4] Peroxisome Proliferator-Activated Receptor γ Coactivator-1α Is a Central Negative Regulator of Vascular Senescence
    Xiong, Shiqin
    Salazar, Gloria
    Patrushev, Nikolay
    Ma, Minhui
    Forouzandeh, Farshad
    Hilenski, Lula
    Alexander, R. Wayne
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2013, 33 (05) : 988 - U308
  • [5] Increasing the level of peroxisome proliferator-activated receptor γ coactivator-1α in podocytes results in collapsing glomerulopathy
    Li, Szu-Yuan
    Park, Jihwan
    Qiu, Chengxiang
    Han, Seung Hyeok
    Palmer, Matthew B.
    Arany, Zoltan
    Susztak, Katalin
    JCI INSIGHT, 2017, 2 (14):
  • [6] Peroxisome proliferator-activated receptor γ coactivator 1α maintains NAD+ bioavailability protecting against steatohepatitis
    Shen, Weiyan
    Wan, Xingyong
    Hou, Jiahui
    Liu, Zhu
    Mao, Genxiang
    Xu, Xiaogang
    Yu, Chaohui
    Zhu, Xudong
    Ju, Zhenyu
    LIFE MEDICINE, 2022, 1 (02): : 207 - 220
  • [7] Fibroblast growth factor 21 increases hepatic oxidative capacity but not physical activity or energy expenditure in hepatic peroxisome proliferator-activated receptor coactivator-1-deficient mice
    Fletcher, Justin A.
    Linden, Melissa A.
    Sheldon, Ryan D.
    Meers, Grace M.
    Morris, E. Matthew
    Butterfield, Anthony
    Perfield, James W.
    Rector, R. Scott
    Thyfault, John P.
    EXPERIMENTAL PHYSIOLOGY, 2018, 103 (03) : 408 - 418
  • [8] Peroxisome proliferator-activated receptor γ coactivator-1 (PGC-1) regulatory cascade in cardiac physiology and disease
    Finck, Brian N.
    Kelly, Daniel P.
    CIRCULATION, 2007, 115 (19) : 2540 - 2548
  • [9] Peroxisome proliferator-activated receptor γ:: the more the merrier?
    Argmann, CA
    Cock, TA
    Auwerx, J
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2005, 35 (02) : 82 - 92
  • [10] Hepatic Peroxisome Proliferator-Activated Receptor Alpha Dysfunction in Porcine Septic Shock
    Vandewalle, Jolien
    Garcia, Bruno
    Timmermans, Steven
    Vanderhaeghen, Tineke
    Van Wyngene, Lise
    Eggermont, Melanie
    Dufoor, Hester
    Van Dender, Celine
    Halimi, Fellanza
    Croubels, Siska
    Herpain, Antoine
    Libert, Claude
    CELLS, 2022, 11 (24)
12345